MiMedx Group (MDXG) Reports Q4 EPS of 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts MDXG Hot Sheet
Join SI Premium – FREE
MiMedx Group (NASDAQ: MDXG) reported Q4 EPS of $0.05, $0.03 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69.9 million versus the consensus estimate of $71.13 million.
GUIDANCE:
MiMedx Group sees FY2017 EPS of $0.31-$0.33, versus the consensus of $0.32. MiMedx Group sees FY2017 revenue of $302-307 million, versus the consensus of $304.8 million.
For earnings history and earnings-related data on MiMedx Group (MDXG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 1stdibs.Com, Inc. (DIBS) Tops Q3 EPS by 2c ; Offers Guidance
- BKV Corporation (BKV) Reports Q3 EPS of $0.36
- Apyx Medical Corp. (APYX) Tops Q3 EPS by 6c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
